You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
|
|---|---|
| Published in |
Molecular Cancer, July 2010
|
| DOI | 10.1186/1476-4598-9-196 |
| Pubmed ID | |
| Authors |
María M Caffarel, Clara Andradas, Emilia Mira, Eduardo Pérez-Gómez, Camilla Cerutti, Gema Moreno-Bueno, Juana M Flores, Isabel García-Real, José Palacios, Santos Mañes, Manuel Guzmán, Cristina Sánchez |
X Demographics
The data shown below were collected from the profiles of 190 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 47 | 25% |
| Indonesia | 12 | 6% |
| Spain | 10 | 5% |
| United Kingdom | 10 | 5% |
| Canada | 10 | 5% |
| Australia | 3 | 2% |
| Georgia | 2 | 1% |
| Mexico | 2 | 1% |
| Germany | 2 | 1% |
| Other | 10 | 5% |
| Unknown | 82 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 168 | 88% |
| Practitioners (doctors, other healthcare professionals) | 16 | 8% |
| Scientists | 3 | 2% |
| Science communicators (journalists, bloggers, editors) | 2 | 1% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| United Kingdom | 2 | <1% |
| South Africa | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 218 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 42 | 19% |
| Researcher | 36 | 16% |
| Student > Ph. D. Student | 28 | 12% |
| Student > Master | 25 | 11% |
| Other | 18 | 8% |
| Other | 33 | 15% |
| Unknown | 43 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 43 | 19% |
| Biochemistry, Genetics and Molecular Biology | 39 | 17% |
| Medicine and Dentistry | 30 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Psychology | 8 | 4% |
| Other | 38 | 17% |
| Unknown | 55 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 420. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#70,418
of 25,774,185 outputs
Outputs from Molecular Cancer
#3
of 1,959 outputs
Outputs of similar age
#128
of 105,668 outputs
Outputs of similar age from Molecular Cancer
#1
of 35 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,959 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,668 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.